Spruce Biosciences is a biopharmaceutical company founded in April 2016, focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need. Its lead product candidate, TA-ERT (tralesinidase alfa), is an enzyme replacement therapy for Mucopolysaccharidosis Type IIIB (MPS IIIB), an ultra-rare fatal genetic disease with no approved therapies. The company seeks U.S. accelerated approval via a Biologics License Application and intends to build a specialized commercial organization in the U.S., EU, and UK, with regional collaborations in other international markets.
expected 2027-02-08
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-09 | 2025-12-31 | 0001193125-26-097558 | EDGAR | 95K words |
| 2025-04-15 | 2024-12-31 | 0000950170-25-053945 | EDGAR | 94K words |
| 2024-03-18 | 2023-12-31 | 0000950170-24-032819 | EDGAR | 100K words |
| 2023-03-16 | 2022-12-31 | 0000950170-23-008456 | EDGAR | 99K words |
| 2022-03-14 | 2021-12-31 | 0000950170-22-003582 | EDGAR | 100K words |
| 2021-03-22 | 2020-12-31 | 0001564590-21-014593 | EDGAR | 98K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-11-09 | 2026-09-30 | 0001193125-26-452714 | EDGAR | 73K words |
| 2026-08-12 | 2026-06-30 | 0001193125-26-345876 | EDGAR | 65K words |
| 2025-11-10 | 2025-09-30 | 0001193125-25-274234 | EDGAR | 65K words |
| 2025-08-14 | 2025-06-30 | 0000950170-25-108888 | EDGAR | 66K words |
| 2025-05-06 | 2025-03-31 | 0000950170-25-064463 | EDGAR | 64K words |
| 2024-11-12 | 2024-09-30 | 0000950170-24-124479 | EDGAR | 66K words |
| 2024-08-12 | 2024-06-30 | 0000950170-24-095461 | EDGAR | 66K words |
| 2024-05-13 | 2024-03-31 | 0000950170-24-058657 | EDGAR | 62K words |
| 2023-11-13 | 2023-09-30 | 0000950170-23-062997 | EDGAR | 66K words |
| 2023-08-14 | 2023-06-30 | 0000950170-23-042439 | EDGAR | 66K words |
| 2023-05-15 | 2023-03-31 | 0000950170-23-021984 | EDGAR | 65K words |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024531 | EDGAR | 66K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-11-09 | 0001193125-26-452707 | EDGAR | 3K words |
| 2026-08-12 | 0001193125-26-345874 | EDGAR | 3K words |
| 2026-07-27 | 0001193125-26-316928 | EDGAR | 1K words |
| 2026-03-20 | 0001193125-26-117888 | EDGAR | 2K words |
| 2026-03-09 | 0001193125-26-097561 | EDGAR | 2K words |
| 2026-02-05 | 0001193125-26-039399 | EDGAR | 2K words |
| 2026-01-08 | 0001193125-26-007038 | EDGAR | 1K words |
| 2025-12-15 | 0001193125-25-318488 | EDGAR | 1K words |
| 2025-12-12 | 0001193125-25-317532 | EDGAR | 1K words |
| 2025-11-10 | 0001193125-25-274216 | EDGAR | 2K words |
99 total filings indexed. 71 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001683553 |
| Ticker | SPRB |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.sprucebiosciences.com |
| Listed | 2020-10-09 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/SPRB (~200 tokens, structured JSON with cryptographic provenance)